Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entecavir Phase II in Lamivudine-Refractory Chronic Hepatitis B
NCT01037166Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Dec 2002
- Primary completion
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of entecavir in Chronic Hepatitis B (CHB), sponsored by Bristol Myers Squibb. Started Dec 2002; status: completed.
02
Drugs
entecavir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT01037166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01037166.